Pharma AI|26 Apr 2026
Chainalysis adds AI agents to its blockchain forensics platform.
The Story
This move aims to counter criminals who are already deploying AI in their operations.
Why It Matters
Chainalysis deploying AI agents to fight AI-enabled crime shows AI is a defense necessity, not just an innovation play. Criminals already use AI, meaning your intellectual property and patient data face new, sophisticated threats. For European CROs and biotech, this shifts AI adoption from a strategic advantage to a core cybersecurity requirement. Protecting sensitive data under GDPR now demands AI-powered vigilance.
What To Do About It
Assess your current data security protocols specifically for AI-driven threats this week
pharma SME AIregulatory affairs AI pharmabiotech startup AI compliancelife sciences SMB AICRO artificial intelligence
